Background: Despite recommendations to discuss the cost of care (CoC) with patients with cancer, little formal guidance is available on how to conduct these sensitive conversations in ways that are acceptable to both patients and providers.
The study and associated materials were approved by the UAB institutional review board. Survivors and cancer center staff who participated gave written informed consent before the interview and received a monetary incentive of $50 at conclusion.
Participants and Recruitment
With about 75% of cancer survivors projected to be 65 years of age or older in 2040 (19) , we focused on older survivors, and purposefully recruited breast cancer survivors aged 60 years or older with different characteristics, including race, treatment type, health insurance, and income. Inclusion criteria were cancer treatment at the UAB Comprehensive Cancer Center within the previous 5 years, English-speaking, physically and mentally able to participate, and residence in the Birmingham area.
Women were first contacted with a letter that described study purpose and requirements and included information on opting out. After the letter was sent, women were contacted by telephone to verify interest, confirm eligibility, and schedule the interview. Recruiters were from the UAB Recruitment and Retention Shared Facility (RRSF), a facility that assists UAB investigators with recruiting for clinical and behavioral research and with conducting qualitative and quantitative participant assessments.
Overall, 411 women were contacted by mail ( Figure) . Among 181 women reached by phone, 127 were screened to confirm eligibility. To achieve a diverse sample of women, recruiters determined eligibility on the basis of inclusion criteria and recruitment goals. Such non-mutually exclusive goals were originally set at 20 white and 20 African American women; 15 with chemotherapy, 15 with radiation, and 10 with surgery only; 20 with low income; and 30 with Medicare. Goals were reviewed and adjusted as recruitment progressed.
Among women screened, 75 were ineligible to participate, mainly because the time since treatment completion was more than 5 years ( Figure) . Of the remaining 52 eligible women, 42 participated.
Because medical and nonmedical personnel may potentially be tasked with discussing CoC with patients, we recruited a diverse group of staff participants, including physicians, oncology nurses, social workers, billing specialists, and patient navigators (nonmedical staff supporting patients through the care process [20, 21] ). We initially contacted a list of potential participants compiled with the help of a patient navigator who provides support to patients with breast cancer. Additional referrals were obtained from interviewees.
An RRSF recruiter contacted participants via e-mail and scheduled the interview. Among 30 cancer center staff approached, 20 agreed to participate, including 2 surgeons, 2 medical oncologists, 2 radiation oncologists, 4 nurses, 3 social workers, 5 patient navigators, and 2 billing specialists. The 10 who did not participate (6 oncology nurses, 3 radiation oncologists, and 1 medical oncologist) either declined participation or could not be scheduled.
Interviews
All interview guides included a first part to evaluate the CoC information fliers (Supplement, available at Annals.org). Several versions of these fliers summarized the potential out-of-pocket costs of breast cancer care for a sample of older women in Medicare: These costs were measured by the amounts due through deductibles, coinsurance, or copayments. Fliers presented the information in 2 formats: costs of all medical care received by time since diagnosis (3-and 6-month intervals), and costs of specific treatments or all medical care received during those treatments (surgery, radiation, and chemotherapy). Costs ranged depending on the flier: For example, costs were on average about $2000 in months 0 to 3 and about $800 in months 10 to 12 from diagnosis, and more than $4000 for medical care during chemotherapy treatment (Supplement).
Survivors first reviewed one flier, and then answered 3 comprehension questions and a 13-item usability and appeal questionnaire (Supplement). The rest of the interview consisted of open-ended questions to further evaluate the fliers and to explore perspectives on the content and timing of the CoC conversation, and the most appropriate person to discuss CoC in the clinic setting. In general, survivors were asked the preferred conversation flow, with probes asking how they would like the provider to introduce the topic, and what kinds of topics they would like to hear or not to hear (Supplement).
The interview guide for cancer center staff consisted of open-ended questions about the flier and about CoC conversations (Supplement). This group was asked to imagine these conversations and what their essential elements should be.
Interviews with survivors were conducted in person in a nonclinical setting on the UAB campus. Interviewers included 2 RRSF interviewers and one of the au- 
Statistical Analysis
Interviews were recorded and transcribed verbatim by an independent commercial transcription company. Transcripts were analyzed using inductive thematic analysis (22, 23) and NVivo 11 Pro software (QSR International). The purpose was to reveal common themes in the data about CoC conversations. Using a constant comparative method (24), 3 investigators (M.P., Y.S., I.H.) independently coded original transcripts to ensure intercoder agreement and consistency in coding. The coders met regularly to discuss the codes and emerging themes and to create a code book that was used to guide each subsequent step in the analysis (22).
Role of the Funding Source
The study was funded by the Robert Wood Johnson Foundation. The funding source had no input into methodology, analysis, authorship decisions, or manuscript preparation.
RESULTS
The 42 survivor-participants, ranging in age from 60 to 79 years, were diverse in age, race, education, income, insurance status, and treatment received ( Table 1) . Of the 20 cancer center staff participants, 10% were male and 30% were African American. Age ranged from 28 to 74 years, and years on the job from 2 to 43 years.
Survivors' Perspectives
Regarding the content of the CoC conversation, survivors highlighted 2 main elements: 1) reassurance: survivors expressed the need to be reassured about the ability to receive treatment regardless of cost, and 2) action: survivors expressed the need to include a discussion of payment options or resources available, so that it would be easier to afford what they perceived to be life-saving treatment ( Table 2) . Conversations should start with acknowledging patients' vulnerability, with such comments as "I know this is a difficult time for you" or "You've been diagnosed, and we know this is a traumatic situation for you; it's going to be difficult." This introduction would be followed by a statement of reassurance, such as "But here are some resources to help ease your stress level." The plan of action could include a discussion of payment plans to make it easier to pay for treatment, or an explanation of resources or financial assistance programs to which survivors could apply. Several survivors emphasized they did not want to hear that there was no help or support available or that the purpose of the CoC conversation was to collect money ( Table 2) .
Survivors generally believed that the best timing for the CoC conversation was after the visit in which they are told about the diagnosis but before treatment starts. One reason was because at diagnosis patients feel highly vulnerable and overwhelmed and would not be in a condition to fully appreciate cost information. Moreover, this information was felt to be more relevant once the treatment plan was established. Several participants also thought that the CoC conversation should be done when patients are ready for it or even initiated by patients, but should not be "forced" on them ( Table 2) .
Most survivors agreed that professionals, such as social workers, billing specialists, or financial counsel- ors, would be the most acceptable personnel to discuss CoC. Many stated that they would not want physicians to discuss CoC, because these providers should focus on the treatment and they would have neither the information nor the time. Some also thought that patients would be embarrassed to talk about affordability problems with the doctors. The person charged with discussing CoC should be kind, compassionate, honest, up-front, and understanding of the vulnerability of cancer patients soon after diagnosis. He or she should be available to assist patients when and if needed. Moreover, this person should be prepared and competent, be able to combine cost information with the details of the patient's insurance plan and prescribed treatment, and be knowledgeable of resources available. One survivor also suggested that 2 people do the CoC conversation: one with expertise regarding insurance and the other who would facilitate access to available resources.
Cancer Center Staff's Perspective
In line with survivors' perspectives on the CoC conversation content, these participants highlighted the elements of reassurance and action ( Table 3) . Interviewees recognized that cost information could cause additional stress to an already vulnerable patient population; thus, they identified the need to provide this information with reassurance that treatment would be delivered and with a discussion of support and resources to help patients afford treatment. As a patient navigator put it, once the treatment is set and the cost is known, "we are moving forward"-moving toward making it possible for the patient to get that treatment. However, the CoC conversation is also an opportunity to help make an informed decision once information about treatment benefits, costs, and options to afford treatments are known. As one oncologist stated, "[I]f ultimately, it is impossible for them to take treatment because of finances or they make that as an educated choice knowing what all the resources are, that is their choice, but I wouldn't want to just necessarily throw a number out there and have them feel like they are going to have to write a check the next day for that amount." Similar to survivors, several of these participants highlighted that the purpose of the CoC conversation was to guide patients and not collect treatment fees. Most cancer center staff agreed that the CoC conversation should occur after that first visit when patients are told they have cancer ( Table 3) . Some believed the conversation would be better received once the treatment decision was made. A few thought the conversation should occur before a treatment plan was chosen, because if not affordable, that plan would need to be reassessed (Table 3) . Furthermore, whereas some staff introduction for you. Go home, talk to your family and show them this document so that everyone can absorb the information. Then next visit we'll go over the next steps to take and what resources we have that you qualify for, everything is a qualification, then we go from there. We're moving forward.
-Patient navigator (20171220_10001)

Timing
After diagnosis/before treatment . . . Very often, coming in at the consult, the initial consult when she's first getting diagnosed. She's more worried about when can I get this off and can I be cured? And I think cost of care is maybe in there, part of maybe some anxiousness and so forth. But I think once she realizes okay. This is my plan. I've got all of this set. Everything is falling into place. She starts to settle down with her anxiety level over the life-threatening part of it. Then talking about cost of care at maybe a subsequent visit might be a better option. 
Person
Not the physician Yeah, it is, would you like to talk with someone, if you anticipate having difficulties with this or would you like to talk about strategies to meet this relative to your own resources, yeah, that would not be an easy conversation. I am sure you could get good at it with practice. But nurses and physicians are not. They are not trained to do that at this point.
-MD (20180208_10013)
Characteristics
Have time Compassionate I definitely wouldn't have a doctor talk about it, because they're already so strapped for time anyway, you spend maybe five minutes with a lot of the patients. I wouldn't have a nurse either because they're also super busy. So I would have the social worker do it because that's their expertise area . . . . And they're used to conversations like that, so the things that people tell them are not going to surprise them. And people really open up to people that they can tell are compassionate. . . . And they're going to have connections with all the resources already who are helping from different drug companies or whatever. -Nurse (20180110_10005) Good communicator I think that it could be anybody who has got a good communication relationship with the patient . . . Anyone who understands who has got the time to do that can relay it to them. No, I don't think it has to be the doctor . . . . People have to have a familiarity, being comfortable with someone to talk about this. I don't know how many people buy a car the first time they walk into a showroom, you know. Discuss their financing and everything, but my experience, the initial encounter has to be entirely related to developing a trust and an understanding and that this kind of a subject for many people will not work very well the first you meet them. -MD (20180208_10013) Knowledgeable A nurse or a social worker, a nurse probably because they will have clinical questions, and give them information about their diagnosis, about a plan of treatment, and you know, discuss this is going to happen first and this is going to happen, and this is going to happen. -Nurse (20180308_10021) * Quotations are presented verbatim. Research identification numbers appear in parentheses after each quotation.
† Words that exemplify the theme appear in boldface.
envisioned addressing CoC with all patients or screening all for financial problems, a few, mainly the patient navigators, would be more comfortable "seizing the moment" and approaching the subject on the basis of cues from patients-for example, missed appointments or problems with insurance. These participants also felt that CoC conversations should occur multiple times over the cancer care continuum ( Table 3) . Many mentioned that patients are not concerned about costs at the beginning of treatment, but many become overwhelmed once they receive medical bills, or changes occur in insurance, employment, or family situations. Therefore, having CoC conversations multiple times would provide the opportunity to promptly link patients to resources and complete treatment. Similar to survivors, these participants thought that social workers or similar figures would be most appropriate for CoC conversations, and agreed that doctors and nurses should not have these conversations, primarily because of lack of time and training. The requisites of the person in charge of CoC conversation include clinical knowledge and understanding of the patient's treatment plan, time to dedicate to the CoC conversation, good communication skills, and an existing relationship with the patient. Overall, the CoC conversation was thought to be a sensitive conversation that patients may not be comfortable with, and for which an established relationship with a trustful and compassionate person would be necessary. The CoC conversation person would also be knowledgeable of resources available and capable of providing what were perceived to be "quality" CoC conversations ( Table 3) .
DISCUSSION
In a tertiary care cancer center in the southern United States, older breast cancer survivors and cancer center staff shared similar views about the content and timing of CoC conversations and the person to conduct them. Overall, participants agreed that these are sensitive conversations with the potential to increase the vulnerability of patients who face a life-threatening illness and potentially expensive treatments. Findings provide some guidance on how to implement CoC conversations in oncology settings.
Despite CoC conversations being a component of high-quality cancer care (1, 8) and increasing advocacy for cost disclosure (12, 18, (25) (26) (27) (28) , they are not common (7) . Current conversations are usually brief and initiated by physicians, and are triggered by concerns about the costs of specific services or insurance coverage limitations (29 -32). The CoC conversations envisioned by our participants had a specific structure and content.
Of note, our interviews started with reviewing fliers that contained estimates of out-of-pocket costs of breast cancer treatment. In this context, participants felt that conversations should not be limited to informing patients about these costs, but they should include the elements of reassurance and action-discussing how patients could cover those costs and afford the care they want. These elements are not systematically covered in current CoC conversations. For example, only 38% of conversations with patients with breast cancer included a discussion of cost-reducing strategies (31) . Although reassuring patients and providing options could be challenging at institutions with fewer resources than ours, our participants and those of other studies reported that knowing costs up front is important (3, 5, (33) (34) (35) , and in one study, physicians who disclosed costs of care were preferred to those who did not (36). As one of our survivor participants expressed, " Overall, physicians were not perceived to be appropriate to discuss costs with patients, mainly because of time constraints. This was perceived to be an activity not to be rushed, in some way distinct and distracting from their purpose of treating patients. This is in contrast with studies where most patients reported wanting CoC conversations to be with physicians (4, 35, 37) . Compared with our study, these studies had a younger sample of respondents in different health care settings (35) , or with different and more severe disease (4, 37) . Thus, the perspectives of younger patients with different types of cancer, or in other health care settings, may differ from those of our participants. In nononcology settings, for example, younger and sicker patients were more willing to discuss costs with physicians than their counterparts (38) . The patient-physician relationship plays a role: Participants who preferred physicians to talk about costs reported a good and trustful relationship with their oncologists. Others also found that trust in the physician would enhance patients' willingness to discuss costs (38) . It is hard to conceive of physicians not being involved in CoC conversations if one of the goals is to present options to make treatment affordable.
Physicians' involvement may depend on the purpose of these conversations. For example, when treatment options are available and differ in anticipated costs to patients, the purpose would be to guide patients in the treatment decision, and physicians would be most appropriate to discuss cost and benefit information. When there is an obvious standard of care or there are no viable options, the purpose would be to guide patients to available payment options and internal and external resources, and other personnel could be most adequate to discuss these strategies. Our participants, despite mainly supporting this latter purpose of the CoC conversation, recognized that CoC conversations could lead to changing treatment plans once costs and options to help patients afford prescribed treatments were considered. Therefore, the question of who should discuss costs with oncology patients remains an empirical question and may depend on the circumstances of each patient's treatment options. Alternatively, more than one person could be designated Survivor and Staff Perspectives on Conversations About Costs of Cancer Care to do CoC conversations. Different models and workflows should be tested to arrive at the most effective CoC conversation.
Our findings suggest that the medical and nonmedical personnel who would be discussing CoC with oncology patients should be trained on showing compassion and be considerate of patients' readiness and willingness to discuss costs, and on establishing a trustful relationship with patients. Given that CoC conversations are perceived to be best before treatment begins, it would be important to design workflows where the person designated to hold CoC conversations, especially nonmedical personnel, has one or more contacts of this type with patients soon after diagnosis. Findings also suggest that the person discussing CoC should be trained to be deeply integrated in the medical decision process and have thorough understanding of patients' recommended treatment plans as well as all options and resources available. Finally, the person discussing CoC should be trained on how to best communicate and provide counseling and guidance in this context.
Future studies should determine whether conversations should be initiated with all patients or whether some type of screening would be necessary. Some survivors believed that not all patients would want to discuss costs. However, providers pointed out that patients may experience CoC challenges not at the time of diagnosis but later in the care trajectory. Therefore, it is necessary to examine whether one conversation or several at different times along the cancer trajectory would be important and effective. Our findings suggest that effectiveness of CoC conversations should be measured by the patients' ability to complete treatment. Currently, CoC conversations may occur in response to nonadherence to treatment (2) and greater financial burden (39); it is not known whether having CoC conversations up front would prevent these adverse outcomes. Moreover, studies should determine whether these conversations would lead to lower costs for patients and the health care system.
Our study has limitations. It was conducted at only 1 institution and may not represent views of providers and survivors across the United States. In addition, we considered only breast cancer survivors who were older than 60 years. Their views may not reflect those of survivors of other cancer types, age group, or sex. The financial toxicity of cancer care may afflict these other populations differently: Breast cancer is not one of the most expensive types of cancer, and for the same type of cancer, younger patients on average have higher costs than older patients (40) . Moreover, owing to the small sample, we could not examine the perspectives of survivors of different socioeconomic status, insurance, or treatment type. Finally, because survivors were a few years removed from diagnosis, recall of the time of treatment may have been compromised, and views may differ from those of patients going through treatment. In one study, for example, respondents undergoing chemotherapy were less likely to discuss costs than respondents not on active treatment (4).
In conclusion, the breast cancer survivors and cancer center staff whom we interviewed generally agreed that CoC conversations were sensitive but critical and should occur toward the beginning of treatment to discuss alternative treatment options, insurance coverage, and potential financial resources. Essential elements included reassurance that cost would not limit receipt of quality care, and discussion of an action plan. Future studies should investigate the best way to integrate these CoC conversations into current medical care to support patients in achieving the best care while reducing the costs and financial toxicity of cancer.
